Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma

Background Outcomes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (PTCL) remain poor. The objective of this study was to evaluate the efficacy and safety of gemcitabine, oxaliplatin and dexamethasone (GemDOx) with or without rituximab as salvage thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qiu-Dan, Wang, Li, Zhu, Hua-Yuan, Liang, Jin-Hua, Xia, Yi, Wu, Jia-Zhu, Fan, Lei, Li, Jian-Yong, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738829/
https://www.ncbi.nlm.nih.gov/pubmed/33391412
http://dx.doi.org/10.7150/jca.47031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738829/
https://www.ncbi.nlm.nih.gov/pubmed/33391412
http://dx.doi.org/10.7150/jca.47031

Ejemplares similares